HSDT - Helius Medical Technologies, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
3/30/2016
Total Revenue
1,822
478
0
0
-
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
8,620
9,939
14,387
4,723
3,646
Selling General and Administrative
16,297
17,214
8,466
5,651
5,672
Total Operating Expenses
24,917
27,153
22,853
10,374
9,317
Operating Income or Loss
-23,633
-26,675
-22,853
-10,374
-9,317
Interest Expense
-
-
-
-
47
Total Other Income/Expenses Net
14,068
-1,948
-5,171
-1,777
2,483
Income Before Tax
-9,565
-28,623
-28,024
-12,040
-6,882
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-9,565
-28,623
-28,024
-12,040
-6,882
Net Income
-9,565
-28,623
-28,024
-12,040
-6,882
Net Income available to common shareholders
-9,565
-28,623
-28,024
-12,040
-6,882
Reported EPS
Basic
-
-1.26
-1.50
-0.72
-0.50
Diluted
-
-1.26
-1.50
-0.72
-0.60
Weighted average shares outstanding
Basic
-
22,786
18,633
16,671
13,305
Diluted
-
22,786
18,633
16,671
13,405
EBITDA
-
-26,616
-22,836
-10,374
-6,835